Joe Cunningham argues that the most-favored-nation drug pricing agreements carry no legislative weight and discusses what the program actually locks in.
Joe Cunningham
Advertisement
Former U.S. Representative Joe Cunningham (D-SC) is a spokesperson for the Pharmaceutical Reform Alliance.
Articles by Joe Cunningham
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: GSK Acquires Trispecific T Cell-Engager from Chimagen, Sanofi & Cheplapharm Form Strategic Partnership
2
Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership
3
Novo Nordisk Rebranding to'Novo'
4
Why Some Diabetes Patients Fail to Respond to Incretin Therapies: Q&A with Dr. Elena Christofides
5